
Factory Supply
Commercial production base with multi-line peptide manufacturing and export coordination.

Commercial production base with multi-line peptide manufacturing and export coordination.

COA, HPLC, MS and batch traceability can be aligned to project requirements.

Unified vial labels, carton language, MOQ planning and buyer-side artwork support.

Structured inquiry fields reduce back-and-forth and speed up technical review.
Answer-first category pages with specs, COA boundaries and quote routes.
Explore Category →Answer-first category pages with specs, COA boundaries and quote routes.
Explore Category →Answer-first category pages with specs, COA boundaries and quote routes.
Explore Category →Answer-first category pages with specs, COA boundaries and quote routes.
Explore Category →Answer-first category pages with specs, COA boundaries and quote routes.
Explore Category →Answer-first category pages with specs, COA boundaries and quote routes.
Explore Category →Answer-first category pages with specs, COA boundaries and quote routes.
Explore Category →Answer-first category pages with specs, COA boundaries and quote routes.
Explore Category →
TR20 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
BT10 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
SEMA20 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
SK5 5 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
RT20 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CU50 50 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
BC2 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to QuoteCustom peptide synthesis, private-label vials and delivery-system projects move through defined technical, sample, artwork, packaging and production approval gates.
Ten controlled milestones from project definition to documented production handoff.
Product format, quantity, label language and destination requirements.
Feasibility, target specification and analytical scope are confirmed.
Pilot formulation and sample route are prepared for evaluation.
Appearance, specification and requested analytical checks are reviewed.
Brand files, label hierarchy, vial count and carton language are aligned.
Print-ready artwork is checked and approved before packaging setup.
Commercial terms, final specification and order details are signed off.
Vial, label and carton components are assembled as a physical mock-up.
The approved prototype becomes the controlled production reference.
Batch production, quality documents and export handoff are coordinated.
Public pages avoid unsupported therapeutic claims. Buyers receive specification, label, document and destination-market review during quotation.
MOQ depends on the product, vial strength, packaging and destination. Standard vial formats are quoted after availability review.
Yes. COA and batch-specific analytical records can be provided according to the confirmed product specification.
Shipping options depend on product type, documents and destination-market import conditions.
Yes. Send sequence, purity target, salt form, quantity and analytical requirements for feasibility review.
Lead time depends on formulation, packaging, artwork and testing scope. Sampling and bulk timelines are quoted separately.
No. Listed products are for laboratory research use only unless a separate signed compliant project specification applies.
Send your product list or custom requirements. We will reply with availability, MOQ, documentation and next-step guidance.
Request A Quote Now